These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2069409)

  • 1. [Tumor markers--personal experience. Immunohistochemical markers for cancer diagnosis].
    Mukai K
    Gan To Kagaku Ryoho; 1991 Jul; 18(8):1383-8. PubMed ID: 2069409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of cytokeratins and additional markers in undifferentiated lymph node metastases of the neck.
    Bartel-Friedrich S; Friedrich RE; Holzhausen HJ
    Anticancer Res; 2000; 20(6D):4931-40. PubMed ID: 11326642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative analysis of alternative and traditional immunohistochemical markers for the distinction of ovarian sertoli cell tumor from endometrioid tumors and carcinoid tumor: A study of 160 cases.
    Zhao C; Bratthauer GL; Barner R; Vang R
    Am J Surg Pathol; 2007 Feb; 31(2):255-66. PubMed ID: 17255771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue microarrays are an effective quality assurance tool for diagnostic immunohistochemistry.
    Hsu FD; Nielsen TO; Alkushi A; Dupuis B; Huntsman D; Liu CL; van de Rijn M; Gilks CB
    Mod Pathol; 2002 Dec; 15(12):1374-80. PubMed ID: 12481020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.
    Ulbright TM
    Mod Pathol; 2005 Feb; 18 Suppl 2():S61-79. PubMed ID: 15761467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of immunohistochemistry in diagnosing renal neoplasms: when is it really useful?
    Shen SS; Truong LD; Scarpelli M; Lopez-Beltran A
    Arch Pathol Lab Med; 2012 Apr; 136(4):410-7. PubMed ID: 22458903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemistry in surgical pathology. The case of the undifferentiated malignant neoplasm.
    Linder J
    Clin Lab Med; 1990 Mar; 10(1):59-76. PubMed ID: 2184980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung carcinoma metastatic to the ovary: a clinicopathologic study of 32 cases emphasizing their morphologic spectrum and problems in differential diagnosis.
    Irving JA; Young RH
    Am J Surg Pathol; 2005 Aug; 29(8):997-1006. PubMed ID: 16006793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From Krukenberg to today: the ever present problems posed by metastatic tumors in the ovary. Part II.
    Young RH
    Adv Anat Pathol; 2007 May; 14(3):149-77. PubMed ID: 17452813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical approaches to the diagnosis of undifferentiated malignant tumors.
    Wick MR
    Ann Diagn Pathol; 2008 Feb; 12(1):72-84. PubMed ID: 18164421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic use of tumor markers, rationale-clinical applications and pitfalls.
    Gion M; Mione R; Barioli P; Dittadi R
    Anticancer Res; 1996; 16(4B):2279-84. PubMed ID: 8694556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of the most sensitive and robust immunohistochemical markers in different categories of ovarian sex cord-stromal tumors.
    Zhao C; Vinh TN; McManus K; Dabbs D; Barner R; Vang R
    Am J Surg Pathol; 2009 Mar; 33(3):354-66. PubMed ID: 19033865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunocytochemical diagnosis of hepatocellular carcinoma and identification of carcinomas of unknown primary metastatic to the liver on fine-needle aspiration cytologies.
    Onofre AS; Pomjanski N; Buckstegge B; Böcking A
    Cancer; 2007 Aug; 111(4):259-68. PubMed ID: 17567831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Histopathology and tumor markers].
    Kijima H; Ueyama Y; Osamura Y
    Rinsho Byori; 2003 Dec; 51(12):1203-15. PubMed ID: 14743744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Use of immunohistochemical markers in the diagnosis of bronchogenic tumors].
    Haskovcová I; Povýsil C
    Sb Lek; 1995; 96(2):105-9. PubMed ID: 8718793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Applications and limitations of immunohistochemistry in the diagnosis of malignant mesothelioma.
    Suster S; Moran CA
    Adv Anat Pathol; 2006 Nov; 13(6):316-29. PubMed ID: 17075297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemistry as a tool in the differential diagnosis of ovarian tumors: an update.
    Baker PM; Oliva E
    Int J Gynecol Pathol; 2005 Jan; 24(1):39-55. PubMed ID: 15626916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical analysis of sox9 in ovarian Sertoli cell tumors and other tumors in the differential diagnosis.
    Zhao C; Bratthauer GL; Barner R; Vang R
    Int J Gynecol Pathol; 2007 Jan; 26(1):1-9. PubMed ID: 17197889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of immunohistochemistry in the differential diagnosis of skin tumors.
    Googe PB; Bhan AK; Mihm MC
    Clin Lab Med; 1990 Mar; 10(1):179-97. PubMed ID: 2184977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical characteristics of melanoma.
    Ohsie SJ; Sarantopoulos GP; Cochran AJ; Binder SW
    J Cutan Pathol; 2008 May; 35(5):433-44. PubMed ID: 18399807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.